Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Life Science VC (Venture Capital) Funds in China in December 2024

Last updated: Dec 2024 A list of 50 VC (Venture Capital) funds that invest in Life science startups based in China. We rank investors based on the number of investments they made in Life science companies from China. We update this investor list every month.

Top 50 Life Science VC (Venture Capital) Funds in China in December 2024

Investor	Life Science China investments
Hillhouse Investment	5
HongShan	5
Qiming Venture Partners	5
EFung Capital	4
Huagai Capital	4
Prox Ventures	4
WuXi AppTec	3
Vinno Capital	3
ULTIMA	3
Legend Capital	3
MiraclePlus	3
Entrepreneurship Relay Group	3
BioVenture	3
Highlight Capital	2
Huimei Capital	2
Orient Securities Capital Investment	2
Puhua Capital	2
Eight Roads Ventures	2
Gaw Capital Partners	2
CentreGold Capital	2
CD Capital	2
Oriental Fortune Capital	2
Innoangel Fund	2
Lilly Asia Ventures	2
Matrix Partners China	2
Med-Fine Capital	2
ASBV	2
Green Pine Capital Partners	2
Zoo Capital	2
CDH Investments	2
Lucion	2
Bits x Bites	2
BOHE Angel Fund	2
Sherpa Healthcare Partners	2
Loyal Valley Capital	2
Northern Light Venture Capital	2
BMC	2
Wanwu Capital	1
Minsheng Securities	1
Starlight Capital	1
Anhui High-tech Industry Investment	1
Step Fund	1
SZHTI Group	1
Saizhi Bole	1
Zhonghuijin Group	1
Hubei Tianchi Enterprise Management	1
October Capital	1
CR Capital Management	1
C-Bridge Capital	1
Jianrui Technology	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Series C
China, United States, Singapore

Portfolio highlights

dinii — Dinii is a mobile order platform for take-out shops.
Ascentium — At Ascentium, we believe in the power of partnership to realise unlimited growth potential.
Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.

We help founders build enduring companies.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Mocaverse — Mocaverse is the Animoca Brands membership NFT collection of 8,888 unique beings: The Mocas. Join the Mocas in the realms to Learn, Play, Do Good, and Build together as we champion our Web3 values!
XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
Aden Energy — Aden Energy is the new energy and energy technology business of Aden Group.Aden Energies helps enterprises, districts, and cities negotiate energy transitions and meet the essential problems of portfolio decarbonization.

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
LongBio Pharma — LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.
Candid Therapeutics — Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Series C
China, United States, India

Portfolio highlights

Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Angel
China, United States, Hong Kong

Portfolio highlights

Baijun Biotech — Baijun Biotechnology is a major player in the field of biopharmaceutical R&D services due to its one-stop biotechnology R&D service platform, strong R&D skills, and extensive industry experience.
Ai Sensing Technology — Ai Sensing Technology is a national high-tech enterprise that focus on the research, development and production of bionic olfactory chips.
Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Investment focus

Medical, Biotechnology, Health Care
Funding Round, Seed, Series A
China, United States, United Kingdom

Portfolio highlights

Zhenyi Yiliao — Zhenyi Yiliao is a medical enterprise focusing on structural heart disease.
Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
Cytonus Therapeutics — Cytonus Therapeutics is a biotech company that develops a therapeutic platform designed to treat immune-related disorders. The Cargocyte platform at Cytonus has diverse applications as it can be engineered to target specific tissues and can deliver strategic therapeutic payloads.

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".

Investment focus

Biotechnology, Pharmaceutical, Health Care
Series A, Series B, Series C
United States, China, Israel

Portfolio highlights

D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.

Investment focus

Manufacturing, Semiconductor, Hardware
Series A, Seed, Series B
China, United States

Portfolio highlights

Glazero Technology — Established in Dec 2020, Glazero is a brand that provides smart home solutions to global markets. It focuses on AIot smart home products, covering smart security, smart lighting and smart cleaning products. Glazero starts from the North American home appliance market, and sells through cross-border e-commerce platforms.
Huachen Core Light — Huachen Core Light is a semiconductor technology company that produces and manufactures optical communications and laser chips.
Beijing Ruidaen Technology Co. — Beijing Ruidaen Technology Co. is a manufacturer of target detection, radio interference, and laser electronic series.

ULTIMA is an investment management firm.

Investment focus

Hardware, Software, Agriculture
Angel, Series A
China

Portfolio highlights

Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, United States, South Korea

Portfolio highlights

Nuwacell — Nuwacell focuses on the research and development, production and clinical transformation application of iPSC-derived cell therapy products.
Zhipu AI — Zhipu AI combines large-scale knowledge map built by itself to form a two-wheel-driven artificial intelligence framework through R&D.
Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.

MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.

Investment focus

Artificial Intelligence, Software, Information Technology
Seed, Angel, Pre-Seed
China, United States, Singapore

Portfolio highlights

TestSprite — AI powered fully automated end-to-end testing solutions to help enterprises launch their products faster.
Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.

Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.

Investment focus

Manufacturing, Software, Enterprise
Series A, Funding Round, Angel
China

Portfolio highlights

Quick Sensing — Quick Sensing is a high-pressure-pressure automotive sensor developer.
Spectral Domain Technology — Spectral Domain Technology is a provider of 5G low-orbit broadband terminals, supplying operators, industrial Internet companies, satellite Internet, and government and enterprise customers with ocean communication needs.
Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Taiwan

Portfolio highlights

Secretech — Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes.
Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.
Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Portugal

Portfolio highlights

Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
ZhongQing Robot — Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.
Qianxun Intelligence — Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.

Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Japan

Portfolio highlights

Sensview — Sensview specializes in the development and production of solid-state imaging chips and detector modules.
Xushui Internet — Xushui Internet provides image equipment monitoring, operation, and maintenance cloud services, large-scale equipment IoT management system, digital integration services for hospital-wide equipment, and remote collaborative image inspection system.
Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.

Orient Securities Capital Investment is an private equity fund business platform.

Investment focus

Health Care, Manufacturing, Software
Series A, Series D, Series C
China

Portfolio highlights

News Dart — News Dart is a manufacturer of precision planetary reducers and helps promote automation and intelligence transmission solutions.
HiStarlink — HiStarlink is a commercial company that makes communication technology like space-borne laser communication terminals and core devices. The main product matrix covers aerospace Advanced core optoelectronic devices, ultra-high-speed communication algorithms, laser communication terminals, and satellite-to-ground laser ground receiving systems.
Shiyu Precision — Shiyu Precision is a high-tech enterprise specializing in the research, development and manufacture of semiconductor automation equipment.

Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Angel
China, United Kingdom, United States

Portfolio highlights

Glbizzia — Glbizzia is a company specializing in genetic testing, data utilization, and biological breeding platforms, focusing on high-throughput omics big data analysis, intelligent omics experiments, and scientific research consulting.
Garen Semiconductor — Garen Semiconductor focuses on the R&D, production and sales of semiconductor materials (such as gallium oxide).
ICleague Technology — ICleague Technology to satisfy situations requiring high processing power, high bandwidth, and low power consumption.

Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.

Investment focus

Software, Health Care, Information Technology
Series B, Series A, Series C
United States, China, India

Portfolio highlights

Bhanzu — Bhanzu's vision is to eradicate global math phobia and change the way students perceive math for a better world.
Dingzhi Dental — Dingzhi Dental is a dental institution service provider that specializes in dental medical chain management, institutional investment, medical education, and supply chain, as well as dental institution franchising and discipline co-construction.
Lighthouse — Lighthouse is a commercial platform for the travel & hospitality industry. The company transforms complexity into confidence by providing actionable market insights, business intelligence, and pricing tools that maximize revenue growth. Lighthouse was previously known as OTA Insight.

Gaw Capital Partners is a positioned private equity fund management company that focuses in real estate markets in greater China and other high barrier-to-entry markets globally. Their services includes gateway real estate funds, separate account investments, venture capital, private equity investment and credit investments.

Investment focus

Information Technology, Hotel, Property Management
Series A, Seed, Series B
China, Singapore, United States

Portfolio highlights

Blackpanda — Asia's premier digital forensics and cyber incident response firm.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Gusto Collective — First brandtech group using the latest technology to help brands create content and experiences across the physical and virtual worlds.

Our team invests in early-stage digital health and consumer startups at CentreGold Capital.

Investment focus

Medical Device, Artificial Intelligence, Internet
Seed, Series A, Angel
United States, China, Canada

Portfolio highlights

Juix — Juix is a power bank rental service that allows people to charge their devices on the go.
Virgo Surgical Video Solutions — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
WeBox — Saltalk is a virtual kitchen platform that focuses on Asian Authentic Food optimized for delivery services.

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B, Seed
China, United States

Portfolio highlights

Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Investment focus

Software, Manufacturing, Information Technology
Series A, Series B, Seed
China, United States

Portfolio highlights

Aiator — Aiator is an artificial intelligence product and technology solutions company focusing on industrial fields and biotechnology. Founded in 2010 by Silicon Valley Artificial Intelligence Scientist in Shenzhen Qianhai DreamWorks, the core members of the team are from the United States, the United Kingdom, Australia and Hong Kong. Currently, there arefour peacock talents and nearly 30 independent intellectual property rights. Weiai Intelligent is committed to carrying out AI empowerment services for enterprises, reducing costs and increasing efficiency.
Mufan Power — Mufan Power is a new energy high-tech enterprise in the field of turbomachinery. It is committed to the development of a new generation of zero-carbon hydrogen power generation technologies and products. Its main products are hydrogen gas turbines, which can be used in distributed energy and data centers. , rail transit, ship power, vehicle power,energy storage peak shaving and other carbon neutral scenarios.
Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT

Innoangel Fund is an investment firm that invests in early stage companies.

Investment focus

Artificial Intelligence, Software, Manufacturing
Angel, Seed, Series A
China, Canada, Hong Kong

Portfolio highlights

Zhiyuan Shenlan — Zhiyuan Shenlan focuses on data-driven biomolecule design and manufacturing.
Saiyun Biotechnology — Saiyun Biotechnology is committed to the development of cutting-edge delivery carrier technology and breakthrough medicinal therapies.
Qiu Shui Semiconductor — Qiu Shui Semiconductor is a semiconductor company that specialized on Micro-LED display technology.Qiu Shui Semiconductor's core products are Micro-LED micro display chips and modules, which are widely utilized in digital car lighting, micro projection, and augmented reality displays.

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

Syneron — Syneron was founded by Sinovation Ventures and is dedicated to using artificial intelligence and biotechnology to address two significant global challenges: the efficient development of novel biological therapies and the low-carbon manufacture of biochemicals.
Avenzo Therapeutics — Developing the next generation of oncology therapies for patients.
Chimagen Biosciences — Chimagen Biosciences is a company that is creating a novel class of multi-functional monoclonal antibodies for cancer therapy.

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
Zerobase — Zerobase is a real-time ZK prover network that prioritizes speed, decentralization, and regulatory compliance. It generates ZK proofs within hundreds of milliseconds and provides decentralized, quick consensus via its HUB ring-wake mechanism, allowing for large-scale commercial application.
Lightwheel AI — Light Wheel Intelligence is offers automated, physically precise and controllable, real and generalizable synthetic data solutions to build AI data infrastructure,

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Series B
China, United States

Portfolio highlights

ZD Medical — ZD Medical develops phase variance optical coherence tomography that can detect macular degeneration and retinal microvascular proliferation caused by diabetes at the same time. It is a non-invasive, early-detection technology for diabetic retinopathy. ZD Medical's phase variance optical coherence tomography can detect both maculardegeneration and retinal microvascular proliferation caused by diabetes. ZD Medical brings together scientific and technological elites from both at home and abroad to pursue the development and manufacture of high-quality medical devices, and is dedicated to providing practical overall solutions for medical diagnosis and clinical treatment in order to benefit humanity's medical and health causes.
Puju Biotechnology — PuJu Biotech focuses on developing an engineering process platform for bioactive filling materials and is dedicated to continuously launching world-class high-end regenerative medicine material products to benefit the vast number of people seeking beauty, as well as providing new material solutions for medical beauty and anti-aging for all agegroups.
Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.

ASBV focuses on early and mid-term venture capital investments.

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Angel
China, Australia, Hong Kong

Portfolio highlights

Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.

Green Pine Capital Partners is a venture capital firm.

Investment focus

Artificial Intelligence, Manufacturing, Software
Series A, Angel, Series B
China, United States, Canada

Portfolio highlights

Baisios — Baisios is a developer of tumor immune cell therapy technology and is dedicated to the growth of the tumor biotherapy industry.
Neurogin — Neurogin is a bioelectronics company that provides reliable monitoring and auxiliary diagnostic tools for clinical and health institutions and focuses on advanced engineering methods for brain science research and clinical diagnosis.
Jiangxing Intelligence — Jiangxing Intelligence was founded in 2018 by internationally renowned scientists, academician of the Canadian Academy of Engineering, and IEEE Fellow Professor Liu Jiangchuan. The company is committed to the development of advanced edge computing technology and its application in the fields of energy Internet, industrial security, and intelligentwarehousing. At the beginning of the company's establishment, it has obtained tens of millions of venture capital from Sequoia Capital China Seed Fund.

Zoo Capital is focusing on early-stage investments in technology, healthcare, and consumer companies.

Investment focus

Artificial Intelligence, Software, Biotechnology
Seed, Series A, Series B
China, Hong Kong, United States

Portfolio highlights

TabbyML — Tabby is an open-source AI coding assistant that empowers developers to code faster and smarter. Discover a self-contained alternative to GitHub Copilot, tailored for your development needs.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Xingan Technology — Xingan Technology is a developer of SiC power semiconductor products.

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Investment focus

Manufacturing, Health Care, Biotechnology
Series A, Series B, Series C
China, United States, Canada

Portfolio highlights

Yida Technology — SaaS, Data
Spear Bio — Successive Proximity Extension Amplification Reaction (SPEAR) technology from Spear Bio enables ultra-sensitive biomarker detection using ultra-small samples.
Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.

Lucion is an influential professional venture capital institute.

Investment focus

Biotechnology, Medical, Manufacturing
Series A, Series B, Seed
China

Portfolio highlights

Keylights — Keylights focuses on the research and development, production, and sales of in vitro diagnostic instruments, it supplies domestic and international consumers with ultra-stable, high-performance, and cost-effective goods and CDMO services.
Runfu Power — Runfu Power is a planetary roller screw R&D manufacturer, committed to the development and production of planetary roller screws.
Northern Hemisphere Technology — Northern Hemisphere Technology is a high-tech company specializing in automotive-grade one-piece molded inductors. Northern Hemisphere focuses on high-performance and high-quality products, uses technology to serve customers and the market.

Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.

Investment focus

Biotechnology, Food and Beverage, Food Processing
Series A, Seed, Series B
China, Israel, Singapore

Portfolio highlights

Ketai Bio — Ketai Bio is a synthetic biology company dedicated to the R&D, production and sales of high value-added bio-based products.
Mojia Bioscience — Mojia Bioscience is a biotechnology company.
Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.

BOHE Angel Fund is an investment Fund.

Investment focus

Health Care, Medical, Biotechnology
Angel, Series A, Seed
China

Portfolio highlights

Levostar — Levostar is a biotechnology company that specializes in the development and manufacture of cell and gene therapy products.
QuarkMed — QuarkMed is a nuclear medicine clinical CRO service company.
Tyligand Bioscience — Tyligand Bioscience is a biotechnology company that focuses on the discovery and development of small molecule therapeutics to help patients with cancer and autoimmune diseases. Tyligand's pharmaceuticals are designed to target and treat tumors and autoimmune disorders, enabling healthcare professionals to prescribe more effective medicine andimprove health outcomes.

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Kenya

Portfolio highlights

Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
Alamar Biosciences — Next-gen proteomic platform with ultra-high sensitivity and multiplexing capability for plasma protein detection and liquid biopsies.
Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.

Loyal Valley Capital is a thematic, research-driven private equity firm.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series C, Series B, Series A
China, United States, Hong Kong

Portfolio highlights

Chabaidao — Chabaidao is a tea drink brand that aims to create surprises through product development and trendy gameplay.
DP Technology — DP Technology is a global leader in the "AI for Science" research paradigm, where AI learns scientific principles and data, then tackles key challenges in scientific research and industrial R&D.DP's commitment to interdisciplinary research has led to the creation of the DP "Particle Universe", an array of pre-trainedlarge science models designed to bridge foundational research with practical industrial applications. DP's software suite includes the Bohrium® Scientific Research Space, Hermite® Computational Drug Design Platform, RiDYMO® Dynamics Platform, and Piloteye® Battery Design Automation Platform. Together, these platforms form a robust foundation for industrial innovation and an open ecosystem for AI in science, fostering advancements in key areas such as drug discovery, energy, material science, and information technology.
DP Technology — Deep Technology uses a new generation of molecular simulation technology to tackle micro-scale industrial design difficulties. Founded in 2018 and is based in Beijing China.

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B, Seed
China, United States, South Korea

Portfolio highlights

RootData — RootData operates as a Web3 asset data platform that pioneers in encapsulating both on-chain and off-chain data of Web3 assets.
Tuliu.com — Tuliu.com is a comprehensive online platform for land transfers in China. The company integrates information like land area, prices, and development trends, forms an evaluation standard and provides farmers with free land value evaluation services.
weshare — Weshare is an IT company that specializes in big data, cloud computing, and artificial intelligence services. Weshare pursue the innovative and harmonious development of people, things, and the business ecosystem which creates maximum value with the trend. They are committed to providing scientific and technological services worldwide throughcontinuous exploration and technologies.

BMC engaged in asset management, investment management and consulting.

Investment focus

CAD, Medical, Computer
Seed, Series B
China

Portfolio highlights

Shengshi Technology — Shengshi Technology is a CFD experimental simulation AI-based platform that does medical engineering research on cardiovascular diseases.
Suzhou Pelotin Biotechnology — Suzhou Pelotin Biotechnology is a research firm specializing in peptides, recombinant proteins, GE antibodies, and protein expression.
Timesintelli — Timesintelli focuses on the development of various end-side artificial intelligence processing chips. The company provides support for a wide range of end-side devices, such as voice, vision, image, display, and other multi-modal intelligent human-computer interactions. Starting from the needs of the landing scene, through the domain-specificarchitecture and customized chip design in the AIoT era where everything is connected.

Wanwu Capital is an investment firm

Investment focus

Artificial Intelligence, Agriculture, SaaS
Series A, Funding Round, Seed
China

Portfolio highlights

Mogic AI — Mogic AI is an advertising technology platform that provides tools to create and launch campaigns by pulling product images into ads using AI.
Huida Tech — Heilongjiang Huida Technology Development Co., Ltd. is a developer of agricultural machinery operation detection equipment. It focuses on the combination of Internet technology and smart agriculture, and provides agricultural production efficiency and management level through information technology. It is a leading domestic agricultural machineryinformatization solution. provider.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.

Minsheng Securities is a securities firm that engages in securities brokerage, securities underwriting, and alternative investments.

Investment focus

Manufacturing, Artificial Intelligence, Software
Series A, Series B, Series C
China

Portfolio highlights

Zhongke Motong — Zhongke Motong is a one-stop overall solution providing comprehensive solutions for intelligent manufacturing. It is a specialized new business that is concentrated on developing comprehensive solutions for sophisticated equipment in the new energy automotive sector.
Aoshi Environmental — Aoshi Environmental specializes in high-performance reverse osmosis and nanofiltration membrane separation, the company offers products for various industries, including drinking water, food, and pharmaceuticals.
Qumei Home Furnishing Group — QuMei Home Furnishings Group designs, manufactures, and markets furniture products in China.

Starlight Capital provides investment and assistance to companies from the digital industry. It searches for businesses that are focusing on digital transformation and helps with its management. Starlight Capital is based in Shanghai, China.

Investment focus

Software, Agriculture, Life Science
Series A, Series E
China

Portfolio highlights

JJC TEC — JJC TEC is an intelligent equipment manufacturer that focuses on the R&D and technical services of intelligent drilling robots and systems in the petroleum industry.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Yunna Technology — Yunna Technology is a provider of intelligent software technology products and services.

Anhui High-tech Industry Investment is engaged in high-tech industry investment and related derivative business.

Investment focus

Medical, Health Care, Life Science
Angel
China

Portfolio highlights

GENERAL BIOL — GENERAL BIOL is a biotechnology and life science service provider company.

Step Fund is a chinese venture firm.

Investment focus

Biotechnology, Software, Electronics
Seed, Series B
China

Portfolio highlights

Kiwimoore — Kiwimoore is a provider of advanced packaging chiplet technology for its customers. The company's intelligent integrated silicon substrate can connect homogeneous or heterogeneous chiplets with more flexibility, higher performance, and smaller size, and integrate to form a new system-on-chip, bringing new value to customers such as OEMs andfabless.
Shanghai Bioprofile — Shanghai Bioprofile is a metabonomics technology service provider.
YEASEN Biotechnology — YEASEN commitment to developing and producing high-quality enzyme products

SZHTI Group is a company that provides asset management and financing services.

Investment focus

Manufacturing, Electronics, Semiconductor
Series A, Angel, Funding Round
China, United States

Portfolio highlights

Light Future — Light Future is a complete metal additive manufacturing solutions provider for the industrial market. It is dedicated to speeding up the global industrialization of metal additive manufacturing technology and focuses on all-inclusive solutions for industrial-grade metal additive manufacturing. This will enable additive manufacturing technology tobecome truly inclusive for industrial use.
Ruibo Automation — Ruibo Automation is a high-tech inventive firm that specializes in Press-Fit pin process automation equipment. It combines independent research and development, manufacturing, and sales.
Xiaoyao Technology — Xiaoyao Technology is an optoelectronic chip design automation.

Saizhi Bole is an investment firm.

Investment focus

Life Science, Biotechnology, Advanced Materials
Series A, Series B
China

Portfolio highlights

Derlead — Derlead is a biotechnology company that develops vitro diagnostic reagent products.
Zhonghao Xinying — Zhonghao Xinying is an AI chip developer, mainly engaged in the research and development, design and sales of artificial intelligence core chips used in various cloud servers.

Zhonghuijin Group is a financial holding group that integrates equity investment, venture capital investment and securities investment.

Investment focus

TV Production, Film Production, Internet
Series A, Angel, Seed
China

Portfolio highlights

Foyoung Drone — Foyoung Drone is a developer of intelligent industrial drone products used in various industries.
Haisai Future — Haisai Future is a digital construction management service provider
Shanghai Bioprofile — Shanghai Bioprofile is a metabonomics technology service provider.

Hubei Tianchi Enterprise Management is engaged in corporate management services.

Investment focus

Medical, Health Care, Life Science
Series A
China

Portfolio highlights

GENERAL BIOL — GENERAL BIOL is a biotechnology and life science service provider company.

October Capital is a family investment firm that finances early and growth stage ventures.

Investment focus

Biotechnology, Manufacturing, Life Science
Series B, Funding Round, Series A
China, United States

Portfolio highlights

Super Years — Super Years is a gene technology company that focuses on the research, development, and manufacturing of high-end life science instruments.
Bostal Drug Delivery — Bostal Drug Delivery develops and manufactures drug preparation products for new drug delivery systems. The company provides pharmaceutical preparation technology platforms to develop innovative drugs, improve new drugs, and high-end generic drugs. It also offers preparation products technical development services for pharmaceutical companies.Thecompany was founded in 2013 and is headquartered in Guangzhou, Guangdong.
Atech Automotive Electronics — Atech Automotive Electronics is a company that designs, develops, manufactures and sells various automotive electronic products

CR Capital Management incubating new business, fostering innovation and leveraging capital and talents.

Investment focus

Manufacturing, Health Care, Apps
Series A, Funding Round, Seed
China, Canada, Germany

Portfolio highlights

Phoenix Wings — Phoenix-Wings is specialized in manufacturing cargo drones and developing air cargo solutions, so that companies can run air cargo delivery operations with ease.
Newlinks Technology — Newlink Group is a provider of technology platforms and tech-enabled services to the energy value chain, principally serving gas and EV charging stations. The Company's broad offering of digital solutions include targeted online marketing tools, cloud-based SaaS systems and supply chain solutions that help merchants drive incremental sales,reduce cost, manage operations and grow profits. The company aims to improve the efficiencies across the value chain and transform the multi-trillion energy industry in the backdrop of China's policy commitment to achieving a carbon-neutral and environmentally friendly society.
IKAS Industrial Automation — IKAS Industrial Automation is provides intelligent manufacturing solutions for IC manufacturing and packaging testing, LED, photovoltaic and other pan-semiconductor manufacturing industries. The company has developed ROPN industrial system modeling as the underlying technology, combined with artificial intelligence and big data, and developed morethan 30 modular products for equipment maintenance, production scheduling and other links in the manufacturing process.

Cambridge Capital is a private equity fund focused on investing in the health care industry. It is principally engaged in the development of advanced and M & A investments, covering all major health areas such as medicine, medical equipment and medical services. Over the past few years, Cambridge Capital has successfully completed investmentprojects covering a number of medical and health segments such as biopharmaceuticals, drug distribution, molecular diagnostics and medical devices.Cambridge Capital is designed to accelerate the development and marketization of modern medical and medical technology through the use of capital to improve the health of the whole people and benefit mankind.

Investment focus

Medical, Health Care, Life Science
Angel, Series B
China, United States

Portfolio highlights

Ascletis — Ascletis is a joint venture between U.S. and Chinese entrepreneurs aimed at building a global specialty therapeutics business dedicated to discovering and developing important new treatments for cancer and infectious diseases. Ascletis leverages U.S./European innovation and pharmaceutical/biotech strategic experience and China'scapital efficiency with a goal of establishing in the near term a sustainable business and accelerated revenues through the in-licensing, late-stage clinical development, and commercialization of new medicines for the growing Chinese pharmaceutical marketplace. At the same time, the company is building long-term value through the discovery, demonstration of clinical proof-of-concept, and global partnering of novel therapeutics for life-threatening diseases.
Leo Summit — Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Providesystematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.

Jianrui Technology operates as an investment firm.

Investment focus

Life Science, Semiconductor, Industrial Manufacturing
Seed
China

Portfolio highlights

Natus — Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity,the company has become a partner of many domestic laboratories.

Investors by industry

Artificial intelligence